Literature DB >> 12925074

Aggressive surgical treatment for patients with T4 rectal cancer.

Y Moriya1, T Akasu, S Fujita, S Yamamoto.   

Abstract

OBJECTIVE: To investigate the outcome of surgical treatment for patients with T4 rectal cancer and to evaluate prognostic factors influencing 5-year disease-free survival. PATIENTS: Of 1600 rectal cancers seen between 1985 and 1998, there were 197 patients with T4 of whom 128 were treated with curative intent. In this retrospective study organ invaded, the type of treatment and outcome were analysed.
RESULTS: Of the 128 patients, 89% had visceral involvement and 11% had pelvic wall involvement. The most frequently involved organ was bladder, followed by prostate and vagina. Low anterior resection was performed in 52, abdomino-perineal resection in 35 and total pelvic exenteration in 41 patients. Of 81 with urinary tract invasion, 50% were treated with bladder-sparing surgery. Pathological examinations showed bladder involvement in only 44 of these and overall 5-year disease-free survival was 57%. Multivariate analysis revealed that body mass index, lymph node metastasis and inflammatory reaction were significant predictors of survival.
CONCLUSION: Completeness of resection is the essential factor influencing oncological outcome.

Entities:  

Mesh:

Year:  2003        PMID: 12925074     DOI: 10.1046/j.1463-1318.2003.00511.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

Review 1.  Surgery for Locally Advanced T4 Rectal Cancer: Strategies and Techniques.

Authors:  Ramzi M Helewa; Jason Park
Journal:  Clin Colon Rectal Surg       Date:  2016-06

2.  En bloc urinary bladder resection for locally advanced colorectal cancer: a 17-year experience.

Authors:  Jimmy C M Li; Charing C N Chong; Simon S M Ng; Raymond Y C Yiu; Janet F Y Lee; Ka Lau Leung
Journal:  Int J Colorectal Dis       Date:  2011-04-28       Impact factor: 2.571

3.  Comparison of immediate surgical outcomes between posterior pelvic exenteration and standard resection for primary rectal cancer: a matched case-control study.

Authors:  Varut Lohsiriwat; Darin Lohsiriwat
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

4.  Giant T4 rectal carcinoma mimicking urinary bladder adenocarcinoma accurately diagnosed by immunohistochemistry and successfully treated with total pelvic exenteration: report of a case.

Authors:  Koh Miura; Terutada Kobayashi; Yuji Funayama; Kouhei Fukushima; Hitoshi Ogawa; Atsushi Oyama; Akihiro Itoh; Takuya Moriya; Takayuki Yamada; Tadayuki Okumoto; Chikashi Shibata; Iwao Sasaki
Journal:  Surg Today       Date:  2008-02-29       Impact factor: 2.549

5.  Selection criteria for the radical treatment of locally advanced rectal cancer.

Authors:  Mansel Leigh Davies; Dean Harris; Mark Davies; Malcolm Lucas; Peter Drew; John Beynon
Journal:  Int J Surg Oncol       Date:  2011-10-13

6.  Radiomic Texture and Shape Descriptors of the Rectal Environment on Post-Chemoradiation T2-Weighted MRI are Associated with Pathologic Tumor Stage Regression in Rectal Cancers: A Retrospective, Multi-Institution Study.

Authors:  Charlems Alvarez-Jimenez; Jacob T Antunes; Nitya Talasila; Kaustav Bera; Justin T Brady; Jayakrishna Gollamudi; Eric Marderstein; Matthew F Kalady; Andrei Purysko; Joseph E Willis; Sharon Stein; Kenneth Friedman; Rajmohan Paspulati; Conor P Delaney; Eduardo Romero; Anant Madabhushi; Satish E Viswanath
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

7.  Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.

Authors:  Heon Jong Yoo; Myong Cheol Lim; Sang-Soo Seo; Sokbom Kang; Chong Woo Yoo; Joo-Young Kim; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.